When was Fennec Pharma founded?

Fennec Pharma was founded in 1996 and raised its 1st funding round 8 years after it was founded.

Where is Fennec Pharma located?

Fennec Pharma is headquartered in Durham, United States.

Who is the current CEO of Fennec Pharma?

Rostislav Raykov of Fennec Pharma.

How many employees does Fennec Pharma have?

As of Aug 31, 2026, the latest employee count at Fennec Pharma is 58.

Is Fennec Pharma a funded company?

Fennec Pharma is a funded company, having raised an undisclosed amount across 11 funding rounds to date. The company's 1st funding round was a $***** Post IPO round, raised on Jun 2004.

When was the latest funding round of Fennec Pharma?

Fennec Pharma's latest funding was a $***** Post IPO round on Sep 27, 2022, with participation from 1 investor.

What is the annual revenue of Fennec Pharma?

Annual revenue of Fennec Pharma is between $10M and $50M as on Dec 31, 2025

Where does Fennec Pharma rank among its competitors?

Fennec Pharma ranks 1st amongst 1 active competitors, none of which are funded.

Fennec Pharma - 2026 Company Profile, Team, Funding & Financials

Company Details

Developer of chemo-protective treatments for cancer patients. It is a clinical-stage biotechnology company developing Sodium Thiosulfate, a chemo-protectant against hearing loss associated with platinum-based chemotherapy for pediatric patients.

Key Metrics

Founded Year

1996

Location

Durham, United States

Stage

Public

Latest Funding Round

Post IPO, Sep 27, 2022, $*****

Investors

Avoro Capital & 6 more

Ranked

1^st among 1 active competitor

Annual Revenue

$10M - $50M as on Dec 31, 2025

Employee Count

58 as on Aug 31, 2026

Exit Details

Public

View Fennec Pharma's full profile

Fennec Pharma is associated with 3 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
FENNEC PHARMACEUTICALS, INC. CIN: 215488297 , United States, Active	Aug 01, 2023	-	-	-
Fennec Pharmaceuticals Inc. CIN: 1211583 , United States, Active	Nov 30, 2003	$10M - $50M (As on Dec 31, 2025)	-	-
Fennec Pharmaceuticals, Inc. CIN: 3733230 , United States, Active	Nov 30, 2003	-	36 (As on Dec 31, 2022)	-

Fennec Pharma got listed on Jun 04, 2001.

Click here to take a look at Fennec Pharma's IPO in detail

Fennec Pharma has raised funding over 11 rounds. Its first funding round was on Jun 2004. Its latest funding round was a Post IPO round on Sep 27, 2022 for $*****. 1 investor participated in its latest round. Fennec Pharma has 7 institutional investors.

Here is the list of recent funding rounds of Fennec Pharma:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 27, 2022	9749431	Post IPO	7616178	2751804	7917983	3972988
Aug 19, 2022	5456011	Post IPO	1934843	7598247	9537339	Petrichor
Feb 04, 2019	2801632	Conventional Debt	8750412	7311242	5616949	Bridge Bank